NewAmsterdam Pharma Co. NV (NAMS)
27.32
+0.46
(+1.73%)
USD |
NASDAQ |
Aug 25, 16:00
27.34
+0.02
(+0.09%)
After-Hours: 17:27
NewAmsterdam Pharma Market Cap : 3.214B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.159B |
| August 21, 2026 | 3.279B |
| August 20, 2026 | 3.268B |
| August 19, 2026 | 3.357B |
| August 18, 2026 | 3.206B |
| August 17, 2026 | 3.165B |
| August 14, 2026 | 3.174B |
| August 13, 2026 | 3.138B |
| August 12, 2026 | 3.274B |
| August 11, 2026 | 3.250B |
| August 10, 2026 | 3.292B |
| August 07, 2026 | 3.290B |
| August 06, 2026 | 3.255B |
| August 05, 2026 | 3.226B |
| August 04, 2026 | 3.241B |
| August 03, 2026 | 3.234B |
| July 31, 2026 | 3.241B |
| July 30, 2026 | 3.320B |
| July 29, 2026 | 3.255B |
| July 28, 2026 | 3.264B |
| July 27, 2026 | 3.525B |
| July 24, 2026 | 3.457B |
| July 23, 2026 | 3.563B |
| July 22, 2026 | 3.698B |
| July 21, 2026 | 3.772B |
| Date | Value |
|---|---|
| July 20, 2026 | 3.461B |
| July 17, 2026 | 3.695B |
| July 16, 2026 | 3.622B |
| July 15, 2026 | 3.730B |
| July 14, 2026 | 3.883B |
| July 13, 2026 | 3.882B |
| July 10, 2026 | 4.113B |
| July 09, 2026 | 4.190B |
| July 08, 2026 | 4.179B |
| July 07, 2026 | 4.315B |
| July 06, 2026 | 4.071B |
| July 02, 2026 | 4.063B |
| July 01, 2026 | 4.102B |
| June 30, 2026 | 3.953B |
| June 29, 2026 | 3.951B |
| June 26, 2026 | 3.877B |
| June 25, 2026 | 3.701B |
| June 24, 2026 | 3.806B |
| June 23, 2026 | 3.663B |
| June 22, 2026 | 3.595B |
| June 18, 2026 | 3.479B |
| June 17, 2026 | 3.517B |
| June 16, 2026 | 3.521B |
| June 15, 2026 | 3.569B |
| June 12, 2026 | 3.546B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ProQR Therapeutics NV | 333.75M |
| Pharming Group NV | 846.51M |
| argenx SE | 63.09B |
| Arcutis Biotherapeutics, Inc. | 3.121B |
| Damora Therapeutics, Inc. | 1.898B |
Market Cap Related Metrics
| PS Ratio | 458.85 |
| PEG Ratio | -0.3578 |
| Price to Book Value | 5.090 |
| Price | 27.32 |
| Earnings Yield | -7.97% |
| PEGY Ratio | -0.3578 |